Skip to main content

Fairmount Funds Management LLC

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 1802528 WEST CONSHOHOCKEN, PA

Position in IKT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,508,750
+$3,018,750 QoQ
Shares Held
8,625,000
0.0% QoQ
Ownership
6.18%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#4
of 106 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Fairmount Funds Management LLC holds $1,512,967,792 across 12 Biotechnology names. IKT ranks #12 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IKT

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,508,750 8,625,000
2026-03-31 $14,490,000 8,625,000
2025-12-31 $17,681,250 8,625,000
2025-12-31 $25,545,257 12,461,101
2025-09-30 $9,922,500 6,125,000
2025-06-30 $11,943,750 6,125,000
2025-03-31 $13,413,750 6,125,000
2024-12-31 $19,906,250 6,125,000